Related Experiment Video
Updated: Jul 7, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic
Wenhui Hu1, Fang Li, Sunila Mahavadi
1Departments of Physiology and Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298, USA. whu@vcu.edu
Abstract:
Initial Ca2+-dependent contraction of the intestinal smooth muscle mediated by G(q)-coupled receptors is attenuated by RGS4 (regulator of G-protein signalling 4). Treatment of colonic muscle cells with IL-1beta (interleukin-1beta) inhibits acetylcholine-stimulated initial contraction through increasing the expression of RGS4. NF-kappaB (nuclear factor kappaB) signalling is the dominant pathway activated by IL-1beta. In the present study we show that RGS4 is a new target gene regulated by IL-1beta/NF-kappaB signalling. Exposure of cultured rabbit colonic muscle cells to IL-1beta induced a rapid increase in RGS4 mRNA expression, which was abolished by pretreatment with a transcription inhibitor, actinomycin D, implying a transcription-dependent mechanism. Existence of the canonical IKK2 [IkappaB (inhibitor of NF-kappaB) kinase 2]/IkappaBalpha pathway of NF-kappaB activation induced by IL-1beta in rabbit colonic muscle cells was validated with multiple approaches, including the induction of reporter luciferase activity and endogenous NF-kappaB-target gene expression, NF-kappaB-DNA binding activity, p65 nuclear translocation, IkappaBalpha degradation and the phosphorylation of IKK2 at Ser(177/181) and p65 at Ser(536). RGS4 up-regulation by IL-1beta was blocked by selective inhibitors of IKK2, IkappaBalpha or NF-kappaB activation, by effective siRNA (small interfering RNA) of IKK2, and in cells expressing either the kinase-inactive IKK2 mutant (K44A) or the phosphorylation-deficient IkappaBalpha mutant (S32A/S36A). An IKK2-specific inhibitor or effective siRNA prevented IL-1beta-induced inhibition of acetylcholine-stimulated PLC-beta (phopsholipase C-beta) activation. These results suggest that the canonical IKK2/IkappaBalpha pathway of NF-kappaB activation mediates the up-regulation of RGS4 expression in response to IL-1beta and contributes to the inhibitory effect of IL-1beta on acetylcholine-stimulated PLC-beta-dependent initial contraction in rabbit colonic smooth muscle.
Insights
Interleukin-1beta increases Regulator of G-protein Signalling 4 expression via the NF-kappaB pathway, inhibiting intestinal smooth muscle contraction. This reveals a new mechanism for controlling muscle response.
Area of Science:
- Gastroenterology
- Molecular Biology
- Cell Signalling
Background:
- Regulator of G-protein signalling 4 (RGS4) attenuates G(q)-coupled receptor-mediated intestinal smooth muscle contraction.
- Interleukin-1beta (IL-1beta) inhibits acetylcholine-stimulated contraction by upregulating RGS4.
- Nuclear Factor kappaB (NF-kappaB) signalling is the primary pathway activated by IL-1beta.
Purpose of the Study:
- To investigate if RGS4 is a target gene of the IL-1beta/NF-kappaB signalling pathway.
- To elucidate the mechanism by which IL-1beta regulates RGS4 expression and affects smooth muscle contraction.
Main Methods:
- Cultured rabbit colonic muscle cells were treated with IL-1beta.
- RGS4 mRNA expression was measured.
- NF-kappaB pathway activation was assessed using reporter assays, DNA binding activity, protein translocation, and phosphorylation.
- Specific inhibitors and small interfering RNA (siRNA) were used to block pathway components.
- Phospholipase C-beta (PLC-beta) activation was measured.
Main Results:
- IL-1beta rapidly increased RGS4 mRNA expression in a transcription-dependent manner.
- The canonical IKK2/IkappaBalpha pathway mediated IL-1beta-induced NF-kappaB activation.
- IL-1beta-induced RGS4 up-regulation was dependent on IKK2, IkappaBalpha, and NF-kappaB.
- Inhibition of IKK2 or NF-kappaB blocked IL-1beta's effect on acetylcholine-stimulated PLC-beta activation.
Conclusions:
- The canonical IKK2/IkappaBalpha/NF-kappaB pathway mediates IL-1beta-induced RGS4 expression in colonic smooth muscle.
- This pathway contributes to IL-1beta's inhibitory effect on acetylcholine-stimulated contraction by modulating PLC-beta activation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Bowel Disease II: Ulcerative Colitis
TGF - β Signaling Pathway
Inflammatory Bowel Disease III: Crohn's Disease
Regulation of the Unfolded Protein Response
Renewal of Intestinal Stem Cells